Why Novo Nordisk’s Drugs Are Anti-Obesity Game-Changers: CNBC Healthy Returns Summit 2023

Поделиться
HTML-код
  • Опубликовано: 25 авг 2024
  • Lars Fruergaard Jørgensen, Novo Nordisk A/S President & CEO
    Karin Conde-Knape, Novo Nordisk Senior Vice President for Global Drug Discovery
    Moderator: Meg Tirrell, CNBC Senior Health & Science Reporter
    More from the CNBC Events: bit.ly/40ZdNd1
    Subscribe to the CNBC Events Marketing Newsletter here: cnb.cx/3nJqzht
    Follow on Twitter: / cnbcevents
    Follow on LinkedIn: / cnbcevents
    #CNBC #healthcare

Комментарии • 1

  • @ZAGIDI
    @ZAGIDI 10 месяцев назад

    I thought Meg left CNBC